Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. MGPI
MGPI logo

MGPI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy MGP Ingredients Inc (MGPI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
18.230
1 Day change
0.11%
52 Week Range
34.980
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

MGP Ingredients Inc (MGPI) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock is currently in a bearish technical trend, with oversold conditions and no immediate positive catalysts. Despite some hedge fund buying, insider selling and weak financial performance suggest caution. Analysts have lowered price targets, and the company's 2026 outlook indicates continued challenges. Given the lack of strong proprietary trading signals and the investor's profile, holding off on buying is recommended.

Technical Analysis

The technical indicators for MGPI show a bearish trend. The MACD is negative at -0.729 and contracting, the RSI is at 17.455 indicating oversold conditions, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its S1 support level of 18.716, with resistance levels at 21.829 and 24.943.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high put-call volume ratio (2.17) indicates bearish sentiment, while the open interest put-call ratio of 0.7 shows a moderate level of bearish positioning. Implied volatility is at 52.5%, with an IV rank of 20.47, suggesting relatively low volatility compared to its historical range.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • Hedge funds are increasing their positions, with buying up 203.87% over the last quarter. Analysts from Roth Capital and Benchmark maintain Buy ratings, citing potential long-term recovery in the company's Branded Spirits portfolio and Ingredient business.

Neutral/Negative Catalysts

  • Insider selling has increased significantly by 431.07% over the last month. Analysts have lowered price targets, citing a challenging 2026 outlook and continued headwinds in the spirits sector. Financial performance in Q4 2025 showed a significant revenue drop (-23.50% YoY) and negative EPS (-6.22). No recent news or congress trading data to suggest positive momentum.

Financial Performance

In Q4 2025, revenue dropped by 23.50% YoY to $138.3M, while net income improved to -$133M (up 220.47% YoY) due to cost adjustments. EPS increased to -6.22, up 225.65% YoY, but gross margin fell to 34.89%, down 15.29% YoY, indicating operational inefficiencies.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed ratings. TD Cowen and Roth Capital lowered price targets to $22 and $32, respectively, citing a weak 2026 outlook. Benchmark initiated coverage with a Buy rating and a $35 price target, highlighting potential recovery in 2027. Overall sentiment is cautious, with concerns about near-term challenges outweighing long-term recovery potential.

Wall Street analysts forecast MGPI stock price to rise
4 Analyst Rating
Wall Street analysts forecast MGPI stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 18.210
sliders
Low
24
Averages
34.75
High
45
Current: 18.210
sliders
Low
24
Averages
34.75
High
45
TD Cowen
Hold
downgrade
$24 -> $22
AI Analysis
2026-02-27
Reason
TD Cowen
Price Target
$24 -> $22
AI Analysis
2026-02-27
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on MGP Ingredients to $22 from $24 and keeps a Hold rating on the shares. The firm said 4Q results beat Street estimates, but 2026 guidance came in well below consensus as management expects another down year for the industry and their business.
Roth Capital
Buy
downgrade
$41 -> $32
2026-02-26
Reason
Roth Capital
Price Target
$41 -> $32
2026-02-26
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on MGP Ingredients to $32 from $41 and keeps a Buy rating on the shares. The company's Q4 results exceeded guidance, the firm's estimates, and consensus, but its 2026 outlook shows that MGP is still at least several quarters away from showing y/y improvements, the analyst tells investors in a research note. Roth adds however that the stock's current valuation overstates the level of risk facing investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MGPI
Unlock Now

People Also Watch